BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17720650)

  • 1. Molecular biology of neuroblastoma.
    Castel V; Grau E; Noguera R; Martínez F
    Clin Transl Oncol; 2007 Aug; 9(8):478-83. PubMed ID: 17720650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma: biology and molecular and chromosomal pathology.
    Schwab M; Westermann F; Hero B; Berthold F
    Lancet Oncol; 2003 Aug; 4(8):472-80. PubMed ID: 12901961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma.
    Maris JM; Hogarty MD; Bagatell R; Cohn SL
    Lancet; 2007 Jun; 369(9579):2106-20. PubMed ID: 17586306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastoma: biology and therapy.
    Matthay KK
    Oncology (Williston Park); 1997 Dec; 11(12):1857-66; discussion 1869-72, 1875. PubMed ID: 9436190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biologic basis for neuroblastoma heterogeneity and risk stratification.
    Maris JM
    Curr Opin Pediatr; 2005 Feb; 17(1):7-13. PubMed ID: 15659956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.
    Rydén M; Sehgal R; Dominici C; Schilling FH; Ibáñez CF; Kogner P
    Br J Cancer; 1996 Sep; 74(5):773-9. PubMed ID: 8795581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma.
    Schulte JH; Eggert A
    Crit Rev Oncog; 2015; 20(3-4):245-70. PubMed ID: 26349419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk estimation of neuroblastoma patients using molecular markers.
    Fischer M; Spitz R; Oberthür A; Westermann F; Berthold F
    Klin Padiatr; 2008; 220(3):137-46. PubMed ID: 18478485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of neuroblastoma regression.
    Brodeur GM; Bagatell R
    Nat Rev Clin Oncol; 2014 Dec; 11(12):704-13. PubMed ID: 25331179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and Genetic Features of Neuroblastoma and Their Clinical Importance.
    Aygun N
    Curr Pediatr Rev; 2018; 14(2):73-90. PubMed ID: 29380702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology and treatment of neuroblastoma.
    Castleberry RP
    Pediatr Clin North Am; 1997 Aug; 44(4):919-37. PubMed ID: 9286292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma.
    Castleberry RP
    Eur J Cancer; 1997 Aug; 33(9):1430-7; discussion 1437-8. PubMed ID: 9337686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroblastoma: biology and staging.
    Mueller S; Matthay KK
    Curr Oncol Rep; 2009 Nov; 11(6):431-8. PubMed ID: 19840520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.
    Newman EA; Nuchtern JG
    Semin Pediatr Surg; 2016 Oct; 25(5):257-264. PubMed ID: 27955728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastoma.
    Matthay KK; Maris JM; Schleiermacher G; Nakagawara A; Mackall CL; Diller L; Weiss WA
    Nat Rev Dis Primers; 2016 Nov; 2():16078. PubMed ID: 27830764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research progress of neuroblastoma related gene variations.
    Cao Y; Jin Y; Yu J; Wang J; Yan J; Zhao Q
    Oncotarget; 2017 Mar; 8(11):18444-18455. PubMed ID: 28055978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
    Peifer M; Hertwig F; Roels F; Dreidax D; Gartlgruber M; Menon R; Krämer A; Roncaioli JL; Sand F; Heuckmann JM; Ikram F; Schmidt R; Ackermann S; Engesser A; Kahlert Y; Vogel W; Altmüller J; Nürnberg P; Thierry-Mieg J; Thierry-Mieg D; Mariappan A; Heynck S; Mariotti E; Henrich KO; Gloeckner C; Bosco G; Leuschner I; Schweiger MR; Savelyeva L; Watkins SC; Shao C; Bell E; Höfer T; Achter V; Lang U; Theissen J; Volland R; Saadati M; Eggert A; de Wilde B; Berthold F; Peng Z; Zhao C; Shi L; Ortmann M; Büttner R; Perner S; Hero B; Schramm A; Schulte JH; Herrmann C; O'Sullivan RJ; Westermann F; Thomas RK; Fischer M
    Nature; 2015 Oct; 526(7575):700-4. PubMed ID: 26466568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The connections between neural crest development and neuroblastoma.
    Jiang M; Stanke J; Lahti JM
    Curr Top Dev Biol; 2011; 94():77-127. PubMed ID: 21295685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.
    Krona C; Carén H; Sjöberg RM; Sandstedt B; Laureys G; Kogner P; Martinsson T
    Int J Oncol; 2008 Mar; 32(3):575-83. PubMed ID: 18292934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.